Lung Malignancies

Area of Science:

• Oncology
• Precision Medicine
• Medical Technology

Background:

• Lung cancer remains a leading cause of cancer-related mortality worldwide.
• Traditional treatment approaches often lack personalization, leading to suboptimal outcomes.
• There is a growing need for innovative strategies to improve lung cancer management.

Purpose of the Study:

• To review the transformative impact of precision medicine on lung cancer care.
• To highlight advancements in screening, diagnostics, and therapeutic interventions.
• To emphasize the integration of novel technologies and personalized strategies.

Main Methods:

• Comprehensive literature review of recent advancements in lung cancer research.
• Analysis of innovations in imaging, biopsy, and surgical techniques.
• Evaluation of the role of immunotherapy, targeted therapies, and artificial intelligence.

Main Results:

• Precision medicine offers enhanced screening and diagnostic capabilities.
• Personalized therapies, including immunotherapy and targeted treatments, show significant promise.
• Minimally invasive surgery and tailored resection strategies improve patient outcomes.
• Artificial intelligence integration aids in optimizing treatment decisions and predicting responses.

Conclusions:

• Precision medicine, through multidisciplinary and individualized approaches, is transforming lung cancer management.
• Technological innovations and personalized therapies are crucial for improving patient survival and quality of life.
• Addressing health disparities is an integral component of advancing precision oncology for lung cancer.